Quantum Cyber N.V. Other Income
Quantum Cyber N.V. (QUCY) reported Other Income of $59.18 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Income Statement › Other Income
ifrs-full:OtherIncome · last filed 2025-09-26
- Quantum Cyber N.V. other income for the quarter ending 2023-12-31 was $391.80K, a 62.98% increase year-over-year.
- Quantum Cyber N.V. other income for the quarter ending 2023-09-30 was $38.65K, a 50.50% decline year-over-year.
- Quantum Cyber N.V. other income for the quarter ending 2023-06-30 was $107.14K, a 508.73% increase year-over-year.
- Quantum Cyber N.V. other income for the quarter ending 2023-03-31 was $63.83K, a 37.02% decline year-over-year.
| Period end | Other Income 3 month | Other Income 6 month | Other Income 6 month as first filed | Other Income 9 month | Other Income 12 month | Other Income 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-06-30 | $59.18K 6-K · filed 2025-09-26 | |||||
| 2024-12-31 | $183.47K 20-F · filed 2025-03-31 | |||||
| 2024-06-30 | $105.85K 6-K · filed 2025-09-26 | |||||
| 2023-12-31 | $391.80K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | $430.45K derived: sum of 2 quarters · filed 2025-03-31 | $537.60K derived: sum of 3 quarters · filed 2025-03-31 | $601.42K 20-F · filed 2025-03-31 | ||
| 2023-09-30 | $38.65K 6-K · filed 2023-11-16 | $145.79K derived: sum of 2 quarters · filed 2023-11-16 | $209.62K 6-K · filed 2023-11-16 | $450.02K derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2023-06-30 | $107.14K 6-K · filed 2023-08-15 | $125.97K 6-K · filed 2024-10-18 | $170.97K 6-K · filed 2023-08-15 | $411.37K derived: sum of 3 quarters · filed 2025-03-31 | $489.45K derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-03-31 | $63.83K 6-K · filed 2023-05-16 | $304.23K derived: sum of 2 quarters · filed 2025-03-31 | $382.31K derived: sum of 3 quarters · filed 2025-03-31 | $399.91K derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2022-12-31 | $240.40K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | $318.49K derived: sum of 2 quarters · filed 2025-03-31 | $336.09K derived: sum of 3 quarters · filed 2025-03-31 | $411.42K 20-F · filed 2025-03-31 | $142.13K 20-F · filed 2023-04-07 | |
| 2022-09-30 | $78.08K 6-K · filed 2023-11-16 | $95.68K derived: sum of 2 quarters · filed 2023-11-16 | $171.01K 6-K · filed 2023-11-16 | |||
| 2022-06-30 | $17.60K 6-K · filed 2023-08-15 | $92.93K 6-K · filed 2023-08-15 | $23.82K 6-K · filed 2022-09-07 | |||
| 2022-03-31 | $101.33K 6-K · filed 2023-05-16 | |||||
| 2021-12-31 | $393.42K 20-F · filed 2024-04-09 | $43.01K 20-F · filed 2022-05-03 | ||||
| 2021-06-30 | $16.36K 6-K · filed 2022-09-07 | |||||
| 2020-12-31 | $8.21K 20-F · filed 2023-04-07 | $30.49K 20-F · filed 2022-05-03 | ||||
| 2019-12-31 | $15.78K 20-F · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |